Title 40

PART 795 SUBPART D

Subpart D - Provisional Health Effects Guidelines

• 15 U.S.C. 2603.

40:35.0.1.1.4.4.1.1	SECTION 795.225	795.225 Dermal pharmacokinetics of DGBE and DGBA.
40:35.0.1.1.4.4.1.2	SECTION 795.228	795.228 Oral/dermal pharmacokinetics.
40:35.0.1.1.4.4.1.3	SECTION 795.231	795.231 Pharmacokinetics of isopropanal.
40:35.0.1.1.4.4.1.4	SECTION 795.232	795.232 Inhalation and dermal pharmacokinetics of commercial hexane.
40:35.0.1.1.4.4.1.5	SECTION 795.250	795.250 Developmental neurotoxicity screen.

---